Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: NEDA-3 After Re-Baselining in the Phase 3 EVOLVE-MS-1 Study.
James D BowenJessica StulcSamuel F HunterHailu ChenJames B LewinMatthew ScaramozzaIvan BožinFlorian Then BerghPublished in: Advances in therapy (2024)
NCT03093324 (EVOLVE-MS-2); NCT02634307 (EVOLVE-MS-1).